Tao, C-Y, Shang, J, Chen, T, Yu, D, Jiang, Y-M, Liu, D, Cheng, G-Y, Xiao, J and Zhao, Z-Z (2019) Impact of antimalarial (AM) on serum lipids in systemic lupus erythematosus (SLE) patients. Medicine, 98 (14). e15030 - e15030.

[img]
Preview
Text
Impact_of_antimalarial__AM__on_serum_lipids_in.32.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (1MB) | Preview

Abstract

Background: Dyslipidemia is a common disorder in systemic lupus erythematosus (SLE) patients. It is still inconclusive whether antimalarial drugs could affect the serum lipids in SLE patients, therefore we conducted a systematic review and meta-analysis of available data to address this issue. Methods: We comprehensively searched the databases of PubMed, EMBASE and Cochrane Library from date of inception to Sep 2018 for both randomized controlled trials (RCTs) and observational studies. Review Manager 5.3 software was used for analysis. We performed meta-analysis using random-effects model and weighted the mean difference (WMD) and its 95% confidence interval (CI). The Q test was used to assess the presence of heterogeneity and the I 2 index was used to quantify the extent of heterogeneity. Results: In total, 8 studies met our selection criteria including 2 RCTs, 2 cohort studies, and 4 case-control studies. There were 717 patients (336 patients in CQ (chloroquine) or HCQ (hydroxychloroquine) group, and 381 patients in control group (SLE patients without the therapy of AM)). Compared with the control group, TC, TG, LDL-C, VLDL-C were associated with a significant decrease, respectively (WMD = −21.40 mg/dL, 95% CI −27.62 to −15.18, P < .00001), (WMD = −29.07 mg/dL, 95% CI −45.28 to −12.86, P = .0004), (WMD = −16.25 mg/dL, 95% CI −28.82 to −3.68, P = .01), (WMD = −6.41 mg/dL, 95% CI −12.39 to 0.44, P = .04), however the change of HDL-C did not reach statistically significance (WMD = 4.42 mg/dL, 95% CI −1.21 to 10.06, P = .12). Conclusions: CQ or HCQ can infect the serum lipids in SLE patients. However, these results should be interpreted with cautions since lacking sufficient RCTs.

Item Type: Article
Additional Information: This is the final published version of the article (version of record). It first appeared online via Ovid Technologies (Wolters Kluwer Health) at https://doi.org/10.1097/md.0000000000015030 - please refer to any applicable terms of use of the publisher.
Uncontrolled Keywords: antimalarial, meta-analysis, serum lipids, systemic lupus erythematosus
Depositing User: Symplectic
Date Deposited: 16 Apr 2019 15:39
Last Modified: 16 Apr 2019 15:39
URI: http://eprints.keele.ac.uk/id/eprint/6196

Actions (login required)

View Item View Item